AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Design Therapeutics, Inc. Director's Dealing 2021

Mar 26, 2021

33059_dirs_2021-03-25_581f3827-074d-479d-aa8e-a91994a0b84d.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Design Therapeutics, Inc. (DSGN)
CIK: 0001807120
Period of Report: 2021-03-25

Reporting Person: Jeffries Sean (Chief Operating Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	807233	Direct